MedPath

A Bilateral Dispensing Clinical Trial of an Sapphire Lens Against Senofilcon A Toric for Astigmatism Lens

Not Applicable
Completed
Conditions
Astigmatism
Interventions
Device: Sapphire contact lenses
Device: senofilcon A contact lenses
Registration Number
NCT02555098
Lead Sponsor
Coopervision, Inc.
Brief Summary

This study was conducted to evaluate the clinical performance of an investigational silicone-hydrogel lens against Senofilcon A toric lens.

The study results were not used for design validation of the investigational product.

Detailed Description

This will be a randomized, bilateral, 2-week cross-over, double-masked, dispensing study comparing the investigational test lens against the Senofilcon A Toric for Astigmatism control lens.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • A person is eligible for inclusion in the study if they:

    1. Are at least 18 years of age and have full legal capacity to volunteer;

    2. Have read and signed an information consent letter;

    3. Are willing and able to follow instructions and maintain the appointment schedule;

    4. Are an adapted soft contact lens wearer;

    5. Require spectacle lens powers in both eyes;

      1. Sphere: between -1.75 to -6.00 diopters and
      2. Astigmatism: between -1.00 to -2.25 and
      3. Axis: 180 ± 20 degrees
    6. Are willing to wear contact lenses in both eyes;

    7. Have manifest refraction visual acuities (VA) equal to or better than logMAR (log of the minimum angle of resolution) equivalent of 20/25 in each eye;

    8. To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit including toric orientation as acceptable.

Exclusion Criteria
  • A person will be excluded from the study if they:

    1. Are participating in any concurrent clinical or research study;
    2. Have any known active* ocular disease and/or infection;
    3. Have a systemic condition that in the opinion of the investigator may affect a study outcome variable;
    4. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
    5. Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
    6. Are pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
    7. Are aphakic;
    8. Have undergone refractive error surgery;

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sapphire contact lensesSapphire contact lensesEach subject randomized to wear either the Investigational lenses (test) or senofilcon A contact lenses (control) as a matched pair and cross over to the second matched pair.
senofilcon Asenofilcon A contact lensesEach subject randomized to wear either the Investigational lenses (test) or senofilcon A contact lenses (control) as a matched pair and cross over to the second matched pair.
Primary Outcome Measures
NameTimeMethod
Subjective Overall Preference2 weeks

Subjective Overall Preference: Sapphire lens, senofilcon A lens, No preference

Subjective Assessment of Visual Quality2 weeks

Subjective assessment of visual quality assessed on a Scale: 0-100 (0=Extremely poor vision all of the time; Cannot function; 100=Excellent vision all of the time)

Subjective Ratings for Comfort2 weeks

Scale 0-100; (0=Cannot be worn; 100=Cannot be felt ever)

Subjective Ratings for Comfort Preference2 weeks

Subjective Ratings for Comfort Preference: Sapphire lens, senofilcon A lens, No preference

Subjective Assessment of Overall Satisfaction2 weeks

Subjective assessment of overall satisfaction on a Scale: 0-100: (0=Extremely dissatisfied; 100=Extremely satisfied)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Family Eye Care Center

🇺🇸

Campbell, California, United States

© Copyright 2025. All Rights Reserved by MedPath